The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
- PMID: 31963897
- PMCID: PMC7023272
- DOI: 10.3390/biom10010161
The Plant-Derived Compound Resveratrol in Brain Cancer: A Review
Abstract
Despite intensive research, malignant brain tumors are among the most difficult to treat due to high resistance to conventional therapeutic approaches. High-grade malignant gliomas, including glioblastoma and anaplastic astrocytoma, are among the most devastating and rapidly growing cancers. Despite the ability of standard treatment agents to achieve therapeutic concentrations in the brain, malignant gliomas are often resistant to alkylating agents. Resveratrol is a plant polyphenol occurring in nuts, berries, grapes, and red wine. Resveratrol crosses the blood‒brain barrier and may influence the central nervous system. Moreover, it influences the enzyme isocitrate dehydrogenase and, more importantly, the resistance to standard treatment via various mechanisms, such as O6-methylguanine methyltransferase. This review summarizes the anticancer effects of resveratrol in various types of brain cancer. Several in vitro and in vivo studies have presented promising results; however, further clinical research is necessary to prove the therapeutic efficacy of resveratrol in brain cancer treatment.
Keywords: brain cancer; drug resistance; glioblastoma; resveratrol.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.J Cell Physiol. 2019 May;234(5):6783-6800. doi: 10.1002/jcp.27409. Epub 2018 Oct 14. J Cell Physiol. 2019. PMID: 30317578
-
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15. J Neurosurg. 2017. PMID: 27419830 Free PMC article.
-
20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.Cancer Sci. 2019 Jan;110(1):389-400. doi: 10.1111/cas.13881. Epub 2018 Dec 14. Cancer Sci. 2019. PMID: 30431207 Free PMC article.
-
The potential of resveratrol against human gliomas.Anticancer Drugs. 2010 Feb;21(2):140-50. doi: 10.1097/CAD.0b013e32833498f1. Anticancer Drugs. 2010. PMID: 20010425 Review.
-
Therapeutic Effect of Resveratrol and its Novel Formulations on Lung Cancer: Focus on Biological Aspects and Underlying Pathways.Curr Med Chem. 2024;31(27):4340-4361. doi: 10.2174/0109298673266259231229050937. Curr Med Chem. 2024. PMID: 38303533 Review.
Cited by
-
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy.ACS Comb Sci. 2020 Dec 14;22(12):669-700. doi: 10.1021/acscombsci.0c00099. Epub 2020 Oct 23. ACS Comb Sci. 2020. PMID: 33095554 Free PMC article. Review.
-
Reversal of Doxorubicin-Induced Bone Loss and Mineralization by Supplementation of Resveratrol and MitoTEMPO in the Early Development of Sparus aurata.Nutrients. 2022 Mar 9;14(6):1154. doi: 10.3390/nu14061154. Nutrients. 2022. PMID: 35334811 Free PMC article.
-
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy.Biomedicines. 2022 May 20;10(5):1187. doi: 10.3390/biomedicines10051187. Biomedicines. 2022. PMID: 35625921 Free PMC article. Review.
-
Co-Encapsulated Synbiotics and Immobilized Probiotics in Human Health and Gut Microbiota Modulation.Foods. 2021 Jun 4;10(6):1297. doi: 10.3390/foods10061297. Foods. 2021. PMID: 34200108 Free PMC article. Review.
-
Synthetic Biology-Driven Microbial Production of Resveratrol: Advances and Perspectives.Front Bioeng Biotechnol. 2022 Jan 20;10:833920. doi: 10.3389/fbioe.2022.833920. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35127664 Free PMC article. Review.
References
-
- Aggarwal B.B., Bhardwaj A., Aggarwal R.S., Seeram N.P., Shishodia S., Takada Y. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 2004;24:2783–2840. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical